Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-266
Closed -$11.1K 589
2024
Q4
$11.1K Hold
266
﹤0.01% 477
2024
Q3
$17.8K Hold
266
﹤0.01% 442
2024
Q2
$31.6K Hold
266
﹤0.01% 394
2024
Q1
$28.3K Hold
266
﹤0.01% 399
2023
Q4
$26.5K Hold
266
﹤0.01% 405
2023
Q3
$27.5K Hold
266
﹤0.01% 382
2023
Q2
$32.3K Hold
266
﹤0.01% 365
2023
Q1
$40.9K Hold
266
0.01% 352
2022
Q4
$48K Hold
266
0.01% 328
2022
Q3
$31K Hold
266
﹤0.01% 364
2022
Q2
$38K Hold
266
0.01% 342
2022
Q1
$46K Hold
266
0.01% 343
2021
Q4
$68K Hold
266
0.01% 306
2021
Q3
$102K Hold
266
0.01% 251
2021
Q2
$63K Hold
266
0.01% 303
2021
Q1
$35K Buy
+266
New +$38.5K ﹤0.01% 364

Other funds holding MRNA

Webster Bank's MRNA Position: Q1 2025 in Review

Webster Bank sold out of Moderna (MRNA) in Q1 2025, closing a stake of 266 shares — an estimated $11.1K sold.

Webster Bank first reported a position in MRNA in Q1 2021 and held it in 16 quarters. The position peaked at $102K in Q3 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Webster Bank reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Webster Bank sold 266 Moderna shares in Q1 2025, an estimated $11.1K.
  • Webster Bank first reported a position in Moderna in Q1 2021 and held it in 16 quarters.
  • Webster Bank's Moderna position peaked at $102K in Q3 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Webster Bank's 13F filing for Q1 2025, filed 4 Apr 2025.